In The News Posted April 15, 2019 Share Posted April 15, 2019 HANGZHOU and SHAOXING, China, April 15, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (Ascletis, 1672.HK), a commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that according to the... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.